Multiple primary squamous cell carcinoma of the head and neckWAUN KI HONG.American journal of clinical oncology. 1987, Vol 10, Num 2, pp 182-183, issn 0277-3732Article

IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody for treatment of head and neck cancerHERBST, Roy S; WAUN KI HONG.Seminars in oncology. 2002, Vol 29, Num 5, pp 18-30, issn 0093-7754, SUP14Conference Paper

TREATMENT OF PREVIOUSLY UNTREATED STAGE III AND IV SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECKWAUN KI HONG; SHAPSHAY SM.1980; OTOLARYNGOL. CLIN. N. AMER.; USA; DA. 1980; VOL. 13; NO 3; PP. 521-528; BIBL. 9 REF.Article

CURRENT CONCEPTS: CHEMOTHERAPY IN HEAD AND NECK CANCERWAUN KI HONG; BROMER R.1983; NEW ENGLAND JOURNAL OF MEDICINE; ISSN 0028-4793; USA; DA. 1983; VOL. 308; NO 2; PP. 75-79; BIBL. 29 REF.Article

Targeted therapy against the epidermal growth factor receptorHERBST, Roy S; WAUN KI HONG.Seminars in oncology. 2002, Vol 29, Num 5, issn 0093-7754, 73 p., SUP14Conference Proceedings

Recent advances in chemoprevention of cancer : Frontiers in cancer researchWAUN KI HONG; SPORN, M. B.Science (Washington, D.C.). 1997, Vol 278, Num 5340, pp 1073-1077, issn 0036-8075Article

Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage diseaseLIPPMAN, S. M; WAUN KI HONG.International journal of radiation oncology, biology, physics. 1989, Vol 17, Num 3, pp 691-694, issn 0360-3016, 4 p.Article

Induction chemotherapy for organ preservation in advanced laryngeal cancer: is there a role?WOLF, G. T; WAUN KI HONG.Head & neck. 1995, Vol 17, Num 4, pp 279-283, issn 1043-3074Conference Paper

Cancer chemopreventionLIPPMAN, S. M; BENNER, S. E; WAUN KI HONG et al.Journal of clinical oncology. 1994, Vol 12, Num 4, pp 851-873, issn 0732-183XArticle

Recent advances in head and neck cancer : larynx preservation and cancer chemoprevention : the seventeenth annual Richard and Hinda Rosenthal Foundation Award LectureWAUN KI HONG; LIPPMAN, S. M; WOLF, G. T et al.Cancer research (Baltimore). 1993, Vol 53, Num 21, pp 5113-5120, issn 0008-5472Article

Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cellsSUN, Shi-Yong; PING YUE; WAUN KI HONG et al.Cancer research (Baltimore). 2000, Vol 60, Num 22, pp 6537-6543, issn 0008-5472Article

Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell linesMAO, L; FAN, Y.-H; LOTAN, R et al.Cancer research (Baltimore). 1996, Vol 56, Num 22, pp 5128-5131, issn 0008-5472Article

Potential of retinoids in cancer preventionKURIE, J. M; LIPPMAN, S. M; WAUN KI HONG et al.Cancer treatment reviews. 1994, Vol 20, Num 1, pp 1-10, issn 0305-7372Article

Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasiaARTEAGA, Carlos L.Seminars in oncology. 2002, Vol 29, Num 5, pp 3-9, issn 0093-7754, SUP14Conference Paper

Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus, and lungLICCIARDELLO, J. T. W; SPITZ, M. R; WAUN KI HONG et al.International journal of radiation oncology, biology, physics. 1989, Vol 17, Num 3, pp 467-476, issn 0360-3016, 10 p.Article

Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cellsSUN, Shi-Yong; PING YUE; WAUN KI HONG et al.Cancer research (Baltimore). 2000, Vol 60, Num 24, pp 7149-7155, issn 0008-5472Article

Chemoprevention of head and neck cancerHUBER, M. H; LIPPMAN, S. M; WAUN KI HONG et al.Seminars in oncology. 1994, Vol 21, Num 3, pp 366-375, issn 0093-7754Article

Retinoid chemoprevention studies in upper aerodigestive tract and lung carcinogenesisLIPPMAN, S. M; BENNER, S. E; WAUN KI HONG et al.Cancer research. Supplement. 1994, Vol 54, pp 2025s-2028s, issn 0576-6656Conference Paper

Safety experience with IMC-C225, an anti-epidermal growth factor receptor antibodyNEEDLE, Michael N.Seminars in oncology. 2002, Vol 29, Num 5, pp 55-60, issn 0093-7754, SUP14Conference Paper

Cancer chemoprevention in the 21st century : Genetics, risk modeling, and molecular targetsWAUN KI HONG; SPITZ, Margaret R; LIPPMAN, Scoff M et al.Journal of clinical oncology. 2000, Vol 18, Num 21, pp 9s-18s, issn 0732-183X, SUPArticle

SEQUENTIAL GERM CELL TUMOR WITHOUT PRIOR INVOLVEMENT OF THE TESTESPENNACCHIO JL; PUGATCH R; DOOS WG et al.1981; J. UROL.; ISSN 0022-5347; USA; DA. 1981; VOL. 126; NO 6; PP. 838-841; BIBL. 19 REF.Article

CHEMOTHERAPY FOR PRIMARY RETROPERITONEAL YOLKSAC TUMOR: REPORT OF A CASEWAUN KI HONG; RAKESH BHUTANI; GERZOF SG et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 47; NO 1; PP. 19-21; BIBL. 16 REF.Article

LACTIC ACIDOSIS IN OAT CELL CARCINOMA WITH EXTENSIVE HEPATIC METASTASESSPECHLER SJ; ESPOSITO AL; KOFF RS et al.1978; ARCH. INTERN. MED.; USA; DA. 1978; VOL. 138; NO 11; PP. 1663-1664; BIBL. 13 REF.Article

Summary of phase II data of docetaxel (Taxotere), an active agent in the first- and second-line treatment of advanced non-small cell lung cancerFOSSELLA, F. V; JIN SOO LEE; BERILLE, J et al.Seminars in oncology. 1995, Vol 22, Num 2, pp 22-29, issn 0093-7754, SUP4Article

Survivin expression in normal human bronchial epithelial cells : an early and critical step in tumorigenesis induced by tobacco exposureQUANRI JIN; MENTER, David G; LI MAO et al.Carcinogenesis (New York. Print). 2008, Vol 29, Num 8, pp 1614-1622, issn 0143-3334, 9 p.Article